Veterinary Vaccines Global Market Opportunities And Strategies To 2033
Including: 1) By Vaccine Type: Live Attenuated Vaccines; Inactivated Vaccines; Toxoid Vaccines; Recombinant Vaccines2) By Disease Type: Anaplasmosis; Canine Parvovirus; Foot & Mouth Disease; Newcastle Disease; Distemper Disease; Influenza; Porcine Reproductive & Respiratory Syndrome (PRRS)3) By Application: Livestock Vaccines; Companion Animal VaccinesCovering: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co. Inc.; Ceva Santé Animale; Elanco Animal Health Incorporated
Veterinary Vaccines Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global veterinary vaccines market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for veterinary vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The veterinary vaccines market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider veterinary vaccines market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by vaccine type by disease type and by application.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the Veterinary Vaccines market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by vaccine type, by disease type and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for veterinary vaccines providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
1) By Vaccine Type: Live Attenuated Vaccines; Inactivated Vaccines; Toxoid Vaccines; Recombinant Vaccines; Other Vaccine Types
2) By Disease Type: Anaplasmosis; Canine Parvovirus; Foot & Mouth Disease; Newcastle Disease; Distemper Disease; Influenza; Porcine Reproductive & Respiratory Syndrome (PRRS)
3) By Application: Livestock Vaccines; Companion Animal Vaccines
Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co. Inc.; Ceva Santé Animale; Elanco Animal Health Incorporated
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; veterinary vaccines indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- 1 Executive Summary
- 1.1 Veterinary Vaccines – Market Attractiveness And Macro Economic Landscape
- 2 Table Of Contents
- 3 List Of Tables
- 4 List Of Figures
- 5 Report Structure
- 6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Veterinary Vaccines Market Definition And Segmentations
- 6.4 Market Segmentation By Vaccine Type
- 6.4.1 Live Attenuated Vaccines
- 6.4.2 Inactivated Vaccines
- 6.4.3 Toxoid Vaccines
- 6.4.4 Recombinant Vaccines
- 6.4.5 Other Vaccine Types
- 6.5 Market Segmentation By Disease Type
- 6.5.1 Anaplasmosis
- 6.5.2 Canine Parvovirus
- 6.5.3 Foot & Mouth Disease
- 6.5.4 Newcastle Disease
- 6.5.5 Distemper Disease
- 6.5.6 Influenza
- 6.5.7 Porcine Reproductive & Respiratory Syndrome (PRRS)
- 6.6 Market Segmentation By Application
- 6.6.1 Livestock Vaccines
- 6.6.2 Companion Animal Vaccines
- 7 Major Market Trends
- 7.1 Innovative Solutions For Canine Health
- 7.2 Advanced RNA-Particle Technology For Rabies Vaccination
- 7.3 Launch Of New Veterinary Vaccine Production Plants
- 7.4 Product Innovations Transforming The Veterinary Vaccine Market
- 7.5 Revolutionary Vaccine Technology Enhances Feline Health
- 8 Veterinary Vaccines Market - Macro Economic Scenario
- 8.1 COVID-19 Impact On The Veterinary Vaccines Market
- 8.2 Impact Of The War In Ukraine On The Veterinary Vaccines Market
- 8.3 Impact Of High Inflation On The Veterinary Vaccines Market
- 9 Global Market Size And Growth
- 9.1 Market Size
- 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 – 2023
- 9.2.2 Market Restraints 2018 – 2023
- 9.3 Forecast Market Growth, 2023 – 2028, 2033 F Value ($ Million)
- 9.3.1 Market Drivers 2023 – 2028
- 9.3.2 Market Restraints 2023 – 2028
- 10 Global Veterinary Vaccines Market Segmentation
- 10.1 Global Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 10.2 Global Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 10.3 Global Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 11 Veterinary Vaccines Market, Regional and Country Analysis
- 11.1 Global Veterinary Vaccines Market, By Region, Historic and Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 11.2 Global Veterinary Vaccines Market, By Country, Historic and Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12 Asia-Pacific Market
- 12.1 Summary
- 12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
- 12.3 Asia-Pacific Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.4 Asia-Pacific Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.5 Asia-Pacific Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.6 Asia-Pacific Veterinary Vaccines Market: Country Analysis
- 12.7 China Market
- 12.8 Summary
- 12.9 Market Overview
- 12.9.1 Country Information
- 12.9.2 Market Information
- 12.9.3 Background Information
- 12.9.4 Government Initiatives
- 12.9.5 Regulations
- 12.9.6 Regulatory Bodies
- 12.9.7 Major Associations
- 12.9.8 Taxes Levied
- 12.9.9 Corporate Tax Structure
- 12.9.10 Investments
- 12.9.11 Major Companies
- 12.10 China Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.11 China Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.12 China Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.13 India Market
- 12.14 India Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.15 India Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.16 India Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.17 Japan Market
- 12.18 Japan Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.19 Japan Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.20 Japan Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.21 Australia Market
- 12.22 Australia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.23 Australia Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.24 Australia Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.25 Indonesia Market
- 12.26 Indonesia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.27 Indonesia Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.28 Indonesia Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.29 South Korea Market
- 12.30 South Korea Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.31 South Korea Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 12.32 South Korea Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13 Western Europe Market
- 13.1 Summary
- 13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major Companies
- 13.3 Western Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.4 Western Europe Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.5 Western Europe Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.6 Western Europe Veterinary Vaccines Market: Country Analysis
- 13.7 UK Market
- 13.8 UK Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.9 UK Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.10 UK Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.11 Germany Market
- 13.12 Germany Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.13 Germany Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.14 Germany Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.15 France Market
- 13.16 France Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.17 France Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.18 France Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.19 Italy Market
- 13.20 Italy Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.21 Italy Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.22 Italy Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.23 Spain Market
- 13.24 Spain Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.25 Spain Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 13.26 Spain Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14 Eastern Europe Market
- 14.1 Summary
- 14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
- 14.3 Eastern Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.4 Eastern Europe Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.5 Eastern Europe Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.6 Eastern Europe Veterinary Vaccines Market: Country Analysis
- 14.7 Russia Market
- 14.8 Russia Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.9 Russia Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 14.10 Russia Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15 North America Market
- 15.1 Summary
- 15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
- 15.3 North America Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.4 North America Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.5 North America Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.6 North America Veterinary Vaccines Market: Country Analysis
- 15.7 USA Market
- 15.8 Summary
- 15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
- 15.10 USA Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.11 USA Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.12 USA Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.13 Canada Market
- 15.14 Canada Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.15 Canada Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 15.16 Canada Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16 South America Market
- 16.1 Summary
- 16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
- 16.3 South America Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.4 South America Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.5 South America Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.6 South America Veterinary Vaccines Market: Country Analysis
- 16.7 Brazil Market
- 16.8 Brazil Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.9 Brazil Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 16.10 Brazil Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 17 Middle East Market
- 17.1 Summary
- 17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
- 17.3 Middle East Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 17.4 Middle East Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 17.5 Middle East Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 18 Africa Market
- 18.1 Summary
- 18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Investments
- 18.2.11 Major Companies
- 18.3 Africa Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 18.4 Africa Veterinary Vaccines Market, Segmentation By Disease Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 18.5 Africa Veterinary Vaccines Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
- 19 Competitive Landscape And Company Profiles
- 19.1 Company Profiles
- 19.2 Zoetis Inc
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
- 19.3 Boehringer Ingelheim International GmbH
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
- 19.4 Merck & Co., Inc.
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
- 19.5 Ceva Santé Animale
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
- 19.6 Elanco Animal Health Incorporated
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview
- 20 Other Major And Innovative Companies
- 20.1 Virbac SA
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.2 Hipra
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.3 Phibro Animal Health
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.4 Vaxxinova
- 20.4.1 Company Overview
- 20.4.2 Products and Services
- 20.5 Biogenesis Bago
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.6 Biovet Private Ltd
- 20.6.1 Company Overview
- 20.6.2 Products and Services
- 20.7 Dechra Pharmaceuticals PLC
- 20.7.1 Company Overview
- 20.7.2 Products And Services
- 20.8 Hester Biosciences
- 20.8.1 Company Overview
- 20.8.2 Products and Services
- 20.9 Ourofino Saúde Animal
- 20.9.1 Company Overview
- 20.9.2 Products And Services
- 20.10 Veterquimica
- 20.10.1 Company Overview
- 20.10.2 Products and Services
- 20.11 MCI Santé Animale
- 20.11.1 Company Overview
- 20.11.2 Products and Services
- 20.12 Calier
- 20.12.1 Company Overview
- 20.12.2 Products and Services
- 20.13 Grand Pharma
- 20.13.1 Company Overview
- 20.13.2 Products and Services
- 20.14 Basso Pancotte
- 20.14.1 Company Overview
- 20.14.2 Products and Services
- 20.15 Biovac Ltd
- 20.15.1 Company Overview
- 20.15.2 Products and Services
- 21 Competitive Benchmarking
- 22 Competitive Dashboard
- 23 Key Mergers And Acquisitions
- 23.1 Boehringer Ingelheim Acquired Saiba Animal Health
- 23.2 Virbac Acquired Sasaeah
- 23.3 Phibro Animal Health Acquired Zoetis’ medicated feed additive (MFA) product portfolio
- 23.4 Merck Animal Health Acquired Elanco Animal Health's Aqua Business
- 23.5 Veterinary Pharmaceutical Solutions Acquired Diamond Animal Health
- 23.6 Virbac Acquired Globion
- 23.7 Mitsui Acquired Sumitomo Pharma Animal Health
- 23.8 Zoetis Acquired Jurox
- 23.9 Mitsui Acquired A Minority Stake In Ouro Fino Saúde Animal Participações
- 23.10 Dechra Pharmaceuticals Acquired Med-Pharmex
- 23.11 Dechra Pharmaceuticals Acquired Piedmont Animal Health
- 23.12 Ceva Santé Animale Acquired Artemis Technologies
- 23.13 Kemin Industries Acquired MEVAC
- 24 Opportunities And Strategies
- 24.1 Global Veterinary Vaccines Market In 2028 – Countries Offering Most New Opportunities
- 24.2 Global Veterinary Vaccines Market In 2028 – Segments Offering Most New Opportunities
- 24.3 Global Veterinary Vaccines Market In 2028 – Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies
- 25 Veterinary Vaccines Global Market Conclusions And Recommendations
- 25.1 Conclusions
- 25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People
- 26 Appendix
- 26.1 Geographies Covered
- 26.2 Market Data Sources
- 26.3 Research Methodology
- 26.4 Currencies
- 26.5 The Business Research Company
- 26.6 Copyright and Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook